𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes

✍ Scribed by Jennifer L. Andruchow; Michael J. Veness; Gary J. Morgan; Kan Gao; Anthony Clifford; Kerwin F. Shannon; Michael Poulsen; Lizbeth Kenny; Carsten E. Palme; Patrick Gullane; Christopher Morris; William M. Mendenhall; Kepal N. Patel; Jatin P. Shah; Christopher J. O'Brien

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
171 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment outcome for 424 primary cases
Treatment outcome for 424 primary cases of clinical stage I cutaneous malignant melanoma of the head and neck
✍ William J. Kane; Patricia Yugueros; Ricky P. Clay; John E. Woods πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

Background. Cutaneous malignant melanoma (CMM) is increasing in frequency. Surgery remains the primary and only curative treatment method. Our aim was to define prognostic factors and outcome predictors for patients with clinical stage I CMM of the head and neck. Methods. Surgical treatment and out

Outcomes after radiotherapy for basaloid
Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck : A case–control study
✍ Juliette Thariat; Anesa Ahamad; Adel K. El-Naggar; Michelle D. Williams; Floyd C πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 439 KB πŸ‘ 3 views

## Abstract ## BACKGROUND. Basaloid squamous cell carcinoma (BSCC) is an uncommon, high‐grade variant of squamous cell carcinoma (SCC) of the head and neck. Its poorer prognosis compared with common SCC remains controversial. The authors investigated the outcomes of patients with BSCC who received

A multicenter phase II study of tgDCC-E1
A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma
✍ Doug Villaret; Bonnie Glisson; Daniel Kenady; Ehab Hanna; Mary Carey; Lyon Gleic πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

## Background: The anti-cancer gene, e1a, can be complexed to a lipid carrier, dc-cholesterol:dope, to form tgdcc-e1a, which can be injected directly into tumors. ## Methods: Twenty-four patients with recurrent, unresectable, head and neck cancer were treated with intratumoral injections of tgdcc

Vinorelbine, cisplatin, and 5-fluorourac
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck : Results of a Phase II multicenter study
✍ Vittorio Gebbia; Glovanni Mantovani; Antonio Farris; Biagio Agostara; Alberto De πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## BACKGROUND. The combination of vinorelbine (VNR), cisplatin (CDDP), and 5-fluoro-